|
1
|
Rabbani F, Grimaldi G and Russo P:
Multiple primary malignancies in renal cell carcinoma. J Urol.
160:1255–1259. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Atilgan D, Uluocak N and Parlaktas BS:
Renal cell carcinoma of the kidney with synchronous ipsilateral
transitional cell carcinoma of the renal pelvis. Case Rep Urol.
2013:1941272013.PubMed/NCBI
|
|
3
|
Hirohashi Y, Torigoe T, Inoda S, Takahashi
A, Morita R, Nishizawa S, Tamura Y, Suzuki H, Toyota M and Sato N:
Immune response against tumor antigens expressed on human cancer
stem-like cells/tumor-initiating cells. Immunotherapy. 2:201–211.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vermeulen L, de Sousa e Melo F, Richel DJ
and Medema JP: The developing cancer stem-cell model: clinical
challenges and opportunities. Lancet Oncol. 13:e83–e89. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keymoosi H, Gheytanchi E, Asgari M,
Shariftabrizi A and Madjd Z: ALDH1 in combination with CD44 as
putative cancer stem cell markers are correlated with poor
prognosis in urothelial carcinoma of the urinary bladder. Asian Pac
J Cancer Prev. 15:2013–2020. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mikami S, Mizuno R, Kosaka T, Saya H, Oya
M and Okada Y: Expression of TNF-α and CD44 is implicated in poor
prognosis, cancer cell invasion, metastasis and resistance to the
sunitinib treatment in clear cell renal cell carcinomas. Int J
Cancer. 136:1504–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ueda K, Ogasawara S, Akiba J, Nakayama M,
Todoroki K, Ueda K, Sanada S, Suekane S, Noguchi M, Matsuoka K and
Yano H: Aldehyde dehydrogenase 1 identifies cells with cancer stem
cell-like properties in a human renal cell carcinoma cell line.
PLoS One. 8:e754632013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
American Cancer Society, . Cancer Facts
& Figures 2013. American Cancer Society, Inc.; Atlanta, GA:
2013
|
|
9
|
Chan KS, Volkmer JP and Weissman I: Cancer
stem cells in bladder cancer: A revisited and evolving concept.
Curr Opin Urol. 20:393–397. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ljungberg B, Bensalah K, Canfield S,
Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L,
Merseburger AS, et al: EAU guidelines on renal cell carcinoma: 2014
update. Eur Urol. 67:913–924. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kirkali Z and Tuzel E: Transitional cell
carcinoma of the ureter and renal pelvis. Crit Rev Oncol Hematol.
47:155–169. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Graves RC and Templeton ER: Combined
tumors of the kidney. J Urol. 5:517–537. 1921.
|
|
13
|
Leveridge M, Isotalo PA, Boag AH and
Kawakami J: Synchronous ipsilateral renal cell carcinoma and
urothelial carcinoma of the renal pelvis. Can Urol Assoc J.
3:64–66. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Min J, Yu D, Shi H and Xie D:
Renal collision tumour of papillary cell carcinoma and chromophobe
cell carcinoma with sarcomatoid transformation: A case report and
review of the literature. Can Urol Assoc J. 8:E536–E539. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Demir A, Onol FF, Bozkurt S and Türkeri L:
Synchronous ipsilateral conventional renal cell and transitional
cell carcinoma. Int Urol Nephrol. 36:499–502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Han P, Wei Q, Shi M and Yang YR:
Ipsilateral synchronous renal pelvic transitional cell carcinoma,
squamous cell carcinoma and adenocarcinoma. Chin Med J (Engl).
117:1590–1591. 2004.PubMed/NCBI
|
|
17
|
Antonelli A, Cozzoli A, Nicolai M, Zani D,
Zanotelli T, Perucchini L, Cunico SC and Simeone C: Nephron-sparing
surgery versus radical nephrectomy in the treatment of
intracapsular renal cell carcinoma up to 7cm. Eur Urol. 53:803–809.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krabbe LM, Bagrodia A, Westerman ME and
Margulis V: Diagnosis and management of upper tract urothelial
carcinoma. Minerva Urol Nefrol. 66:37–48. 2014.PubMed/NCBI
|
|
19
|
Abouassaly R, Alibhai SM, Shah N,
Timilshina N, Fleshner N and Finelli A: Troubling outcomes from
population-level analysis of surgery for upper tract urothelial
carcinoma. Urology. 76:895–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Creighton CJ, Li X, Landis M, Dixon JM,
Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A,
Herschkowitz JI, et al: Residual breast cancers after conventional
therapy display mesenchymal as well as tumor-initiating features.
Proc Natl Acad Sci USA. 106:13820–13825. 2009. View Article : Google Scholar : PubMed/NCBI
|
